期刊文献+

肌钙蛋白Ⅰ对慢性阻塞性肺疾病患者院内死亡的临床预测价值 被引量:3

Clinical predictive value of cTnI in mortality of hospitalized COPD patients
下载PDF
导出
摘要 目的调查研究升高的肌钙蛋白Ⅰ(cTnI)水平对慢性阻塞性肺疾病(chronic obstructive pulmonary diseases,COPD)患者存活的预测价值。方法采用整群抽样方法确定此次调查对象并进行统计学分析。结果从3个医院选出符合入选标准者共4960例,其中979例检测了血清cTnI,男710例,女269例,年龄(73.1±10.5)岁。除糖尿病和性别因素外,cTnI水平与COPD死亡组的年龄、缺血性心脏病、充血性心力衰竭、心房颤动、二氧化碳分压(PaCO2)、血氧分压(PaO2)差异均有统计学意义(P<0.01)。Logsitic多因素分析显示,年龄、缺血性心脏病和cTnI水平与死亡明显相关(相对危险度分别为2.7832、2.5350和1.3111,95%CI 0.99753~5.6199,均P<0.05),而PaCO2和PaO2与死亡的相关性明显较弱(P>0.05)。结论继缺血性心脏病和年龄之后,cTnI水平成为COPD第3个最有价值的病死率的预测因素,优于动脉血气值。 Objective To study the predictive value of the elevated cyclic troponin-I(cTnI)level to the survival of chronic obstructive pulmonary disease(COPD)patients.Methods There are 4960 cases picked out of three hospitals.Of all 4960 cases,serum cTnI levels in 979 cases were measured,710 male,269 female,mean=(73.1±10.5)yrs.The group sampling method was used to assess the data and statistical analysis was carried out.Results It was indicated that there was a significant correlation between the cTnI level and age,smoking,anemic heart disease,congestive heart failure,auricular fibrillation,PaCO2 and PaO2(all P0.01)in the mortality of CDPD patients.Diabetes and sex,however,did not play a major role.Except PaCO2 and PaO2,cTnI level,age and anemic heart disease were obviously correlative with the death of CDPD patients(RR=1.3111,2.5350 and 2.7832,95%CI:0.99753-5.6199,all P0.01),which was reflected by Logsitic multivariate analysis.Conclusions The cTnI may be the third most valuable predictive marker after age and anemic heart disease for the death of COPD patients,and it is a better marker than artery blood-gas data.
出处 《中华保健医学杂志》 2011年第5期389-391,共3页 Chinese Journal of Health Care and Medicine
基金 全军医药卫生科研基金课题(06MA290)
关键词 慢性阻塞性肺疾病 肌钙蛋白Ⅰ 分析 Chronic obstructive pulmonary diseases cTnI Analysis
  • 相关文献

参考文献2

二级参考文献22

  • 1王声湧.死因分析与评价方法的进展[J].中华流行病学杂志,1996,17(4):239-242. 被引量:166
  • 2Pauwels RA,Rabe KF.Burden and clinical features of chronic obstructive pulmonary disease (COPD).Lancet,2004,364:613-620.
  • 3Murray CJ.Lopez AD.Mortality by cause for eight regions of the world:global burden of disease study.Lancet,1997,349:1269-1276.
  • 4北京协和医院世界卫生组织疾病分类合作中心.疾病和有关健康问题的国际统计分类(第十次修订本).董景五,译.2版.北京:人民卫生出版社,2006.
  • 5中国疾病预防控制中心慢性非传染性疾病预防控制中心.全国疾病监测系统死因监测数据集2004/2005.北京:军事医学出版社,2009.
  • 6Gardner JW,Sanborn JS.Years of potential life lost (YPLL)-What dpes it measure? Epidemiology,1990,1:322-329.
  • 7World Health Organization.The World Health Report 2002:reducing the risks,promoting healthy life.Geneva:WHO,2002.
  • 8Artnik B,Vidmar G,Javornik J,et al.Premature mortality in Slovenia in relation to selected biological,socioeconomic,and geographical determinants.Croat Med J,2006,47:103-113.
  • 9Varkey AB.Chronic obstructive pulmonary disease in women:exploring gender differences.Curr Opin Pulm Med,2004,10:98-103.
  • 10中国疾病预防控制中心慢性非传染性疾病预防控制中心.中国慢性病及其危险因素监测报告2007.北京:人民卫生出版社,2010.

共引文献1017

同被引文献66

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部